- About
- Products
- Services
- Locations
- Partners
- Developers
- Resources
- News/Events
- Customers
Financials
2007 Third-Quarter Financial Statements
- Unaudited Condensed Consolidated Statements of Operations
- Unaudited Condensed Consolidated Balance Sheets
- Reconciliations of GAAP to Non-GAAP Measures
- Forward Looking Guidance
The following supplemental tables provide non-GAAP financial measures used by the company's management to evaluate operational results. The company believes this information may be useful to investors. In addition to disclosing financial results calculated in accordance with U.S. generally accepted accounting principles (GAAP), the company's earnings release contains non-GAAP financial measures that exclude the income statement effects of share-based compensation, amortization of purchase product rights, non recurring restructuring and impairment charges. The non-GAAP financial measures disclosed by the company should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations to those financial statements should be carefully evaluated. The non-GAAP financial measures used by the company may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies.
Set forth below are reconciliations of the non-GAAP financial measures to the most directly comparable GAAP financial measures.
For additional information regarding these non-GAAP financial measures, see the Form 8-K dated October 23, 2007 that Entrust has filed with the Securities and Exchange Commission.
|
ENTRUST, INC. SUPPLEMENTAL RECONCILIATIONS OF GAAP TO NON-GAAP MEASURES (in thousands, except per share data) |
||||
|---|---|---|---|---|
|
Three Months Ended |
Nine Months Ended |
|||
2007 |
2006 |
2007 |
2006 |
|
Reconciliation of net loss per GAAP to Non-GAAP loss: |
||||
GAAP net loss |
$(1,501) |
$(3,239) |
$(7,159) |
$(13,671) |
Adjustments for share-based compensation expense: |
||||
| Cost of revenues | 77 |
68 |
225 |
191 |
| Sales and marketing | 305 |
282 |
933 |
635 |
| Research and development | 173 |
132 |
574 |
262 |
| General and administrative | 498 |
442 |
1,450 |
1,111 |
| Amortization of other purchased intangibles: | ||||
| Cost of revenues | 38 |
51 |
114 |
51 |
| Sales and marketing | 209 |
217 |
666 |
251 |
Amortization of purchased product rights |
355 |
319 |
1,032 |
738 |
Restructuring charges and adjustments |
- |
- |
2,765 |
|
Write-down of long-term strategic and equity investments |
- |
- |
3,016 |
|
Tax effect on Non-GAAP adjustments |
- |
- |
- |
- |
Non-GAAP loss |
$154 |
$(1,728) |
$(2,165) |
$(4,651) |
Reconciliation of net loss per diluted share according to GAAP to Non-GAAP loss per diluted share: |
||||
GAAP net loss per diluted share |
($0.02) |
($0.05) |
($0.12) |
($0.23) |
Adjustments for share-based compensation expense |
0.01 |
0.01 |
0.05 |
0.04 |
Amortization of other purchased intangibles: |
- |
- |
0.01 |
0.01 |
Amortization of purchased product rights |
0.01 |
0.01 |
0.02 |
0.01 |
Restructuring charges and adjustments |
- |
- |
- |
0.04 |
Write-down of long-term strategic and equity investments |
- |
- |
- |
0.05 |
Tax effect on Non-GAAP adjustments |
- |
- |
- |
- |
0.02 |
0.02 |
0.08 |
0.15 |
|
Non-GAAP income (loss) per diluted share |
$0.00 |
($0.03) |
($0.04) |
($0.08) |
Weighted average common shares used |
60,987 |
59,807 |
60,717 |
59,814 |
| Forward Looking Guidance Earnings Per Share |
||
|---|---|---|
| Second Half 2007 | Full Year 2007 | |
U.S. GAAP measure |
($0.02) |
($0.12) |
Adjustments to exclude the effects of amortization of purchased intangible assets |
$0.02 |
$0.04 |
Adjustments to exclude the effects of expenses related to stock-based compensation |
$0.04 |
$0.08 |
Non-GAAP figures |
$0.04 |
$0.00 |
|
Forward Looking Guidance |
|
|---|---|
Range |
|
U.S. GAAP measure |
$25.5 |
Adjustments to exclude the effects of amortization of purchased intangible assets |
$0.6 |
Adjustments to exclude the effects of expenses related to stock-based compensation |
$1.1 |
Non-GAAP figures |
$23.8 |